25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Sienna Biopharmaceuticals Inc
Buy, Hold or Sell?

Let's analyze Sienna Biopharmaceuticals Inc together

I guess you are interested in Sienna Biopharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sienna Biopharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Sienna Biopharmaceuticals Inc

I send you an email if I find something interesting about Sienna Biopharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of Sienna Biopharmaceuticals Inc (30 sec.)










1.2. What can you expect buying and holding a share of Sienna Biopharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
25.0%

What is your share worth?

Current worth
$0.86
Expected worth in 1 year
$-7.50
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
$-8.36
Return On Investment
-8,362,759.8%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Sienna Biopharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-30.20 - $-36.12
Total Value Per Share
$-29.34 - $-35.26

2.2. Growth of Sienna Biopharmaceuticals Inc (5 min.)




Is Sienna Biopharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$26.5m$91.1m-$64.6m-243.1%

How much money is Sienna Biopharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$73.3m-$50.5m-$22.7m-31.1%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Sienna Biopharmaceuticals Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Sienna Biopharmaceuticals Inc?

Welcome investor! Sienna Biopharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Sienna Biopharmaceuticals Inc.

First you should know what it really means to hold a share of Sienna Biopharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Sienna Biopharmaceuticals Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sienna Biopharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sienna Biopharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.86. Based on the TTM, the Book Value Change Per Share is $-2.09 per quarter. Based on the YOY, the Book Value Change Per Share is $2.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sienna Biopharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.38-2,377,125.3%-2.38-2,377,125.3%-1.64-1,635,363.6%-1.27-1,265,647.5%-1.27-1,265,647.5%
Usd Book Value Change Per Share-2.09-2,090,690.0%-2.09-2,090,690.0%2.242,235,120.9%0.22215,004.4%0.22215,004.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.37367,160.1%0.37367,160.1%
Usd Total Gains Per Share-2.09-2,090,690.0%-2.09-2,090,690.0%2.242,235,120.9%0.58582,164.5%0.58582,164.5%
Usd Price Per Share2.32-2.32-18.15-5.12-5.12-
Price to Earnings Ratio-0.98--0.98--11.10--3.02--3.02-
Price-to-Total Gains Ratio-1.11--1.11-8.12-3.51-3.51-
Price to Book Ratio2.70-2.70-6.15-2.21-2.21-
Price-to-Total Gains Ratio-1.11--1.11-8.12-3.51-3.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.37
Usd Book Value Change Per Share-2.090.22
Usd Total Gains Per Share-2.090.58
Gains per Quarter (10000000 shares)-20,906,899.625,821,645.23
Gains per Year (10000000 shares)-83,627,598.4823,286,580.93
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-83627598-8362760814686403860017823286571
20-167255197-167255206293728061720035646573152
30-250882795-250882804440592092580053469859733
40-334510394-334510402587456123440071293146314
50-418137992-4181380007343201543000890116432895
60-501765591-5017655988811841851601068139719476
70-585393189-58539319610280482160201246163006057
80-669020788-66902079411749122468801424186292638
90-752648386-75264839213217762777401602209579219
100-836275985-83627599014686403086001780232865800

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.04.00.00.0%0.04.00.00.0%0.04.00.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.01.00.075.0%3.01.00.075.0%3.01.00.075.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.03.025.0%1.00.03.025.0%1.00.03.025.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.01.00.075.0%3.01.00.075.0%3.01.00.075.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Sienna Biopharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.091-2.0910%2.235-194%0.215-1072%0.215-1072%
Book Value Per Share--0.8600.8600%2.951-71%1.164-26%1.164-26%
Current Ratio--2.0702.0700%9.386-78%4.528-54%4.528-54%
Debt To Asset Ratio--0.7520.7520%0.334+126%0.507+48%0.507+48%
Debt To Equity Ratio--0.5070.5070%0.531-5%0.820-38%0.820-38%
Dividend Per Share----0%-0%0.367-100%0.367-100%
Eps---2.377-2.3770%-1.635-31%-1.266-47%-1.266-47%
Free Cash Flow Per Share---1.997-1.9970%-1.338-33%-1.060-47%-1.060-47%
Free Cash Flow To Equity Per Share---0.834-0.8340%2.117-139%0.446-287%0.446-287%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---36.117--------
Intrinsic Value_10Y_min---30.201--------
Intrinsic Value_1Y_max---1.808--------
Intrinsic Value_1Y_min---1.757--------
Intrinsic Value_3Y_max---6.813--------
Intrinsic Value_3Y_min---6.409--------
Intrinsic Value_5Y_max---13.482--------
Intrinsic Value_5Y_min---12.266--------
Market Cap3090.750-2319900%71705400.00071705400.0000%560971125.000-87%158169131.250-55%158169131.250-55%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.000-2319900%2.6982.6980%6.151-56%2.212+22%2.212+22%
Pe Ratio0.000+100%-0.976-0.9760%-11.098+1037%-3.019+209%-3.019+209%
Price Per Share0.000-2319900%2.3202.3200%18.150-87%5.118-55%5.118-55%
Price To Free Cash Flow Ratio0.000+100%-1.162-1.1620%-13.564+1068%-3.681+217%-3.681+217%
Price To Total Gains Ratio0.000+100%-1.110-1.1100%8.120-114%3.505-132%3.505-132%
Quick Ratio--1.9931.9930%9.036-78%4.217-53%4.217-53%
Return On Assets---0.683-0.6830%-0.369-46%-0.841+23%-0.841+23%
Return On Equity---0.460-0.4600%-0.588+28%-1.206+162%-1.206+162%
Total Gains Per Share---2.091-2.0910%2.235-194%0.582-459%0.582-459%
Usd Book Value--26581000.00026581000.0000%91199000.000-71%35987000.000-26%35987000.000-26%
Usd Book Value Change Per Share---2.091-2.0910%2.235-194%0.215-1072%0.215-1072%
Usd Book Value Per Share--0.8600.8600%2.951-71%1.164-26%1.164-26%
Usd Dividend Per Share----0%-0%0.367-100%0.367-100%
Usd Eps---2.377-2.3770%-1.635-31%-1.266-47%-1.266-47%
Usd Free Cash Flow---61732000.000-61732000.0000%-41358000.000-33%-32769250.000-47%-32769250.000-47%
Usd Free Cash Flow Per Share---1.997-1.9970%-1.338-33%-1.060-47%-1.060-47%
Usd Free Cash Flow To Equity Per Share---0.834-0.8340%2.117-139%0.446-287%0.446-287%
Usd Market Cap3090.750-2319900%71705400.00071705400.0000%560971125.000-87%158169131.250-55%158169131.250-55%
Usd Price Per Share0.000-2319900%2.3202.3200%18.150-87%5.118-55%5.118-55%
Usd Profit---73314000.000-73314000.0000%-50545000.000-31%-39244500.000-46%-39244500.000-46%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---2.091-2.0910%2.235-194%0.582-459%0.582-459%
 EOD+3 -5MRQTTM+0 -0YOY+4 -255Y+4 -2710Y+4 -27

3.3 Fundamental Score

Let's check the fundamental score of Sienna Biopharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.000
Price to Book Ratio (EOD)Between0-10.000
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.993
Current Ratio (MRQ)Greater than12.070
Debt to Asset Ratio (MRQ)Less than10.752
Debt to Equity Ratio (MRQ)Less than10.507
Return on Equity (MRQ)Greater than0.15-0.460
Return on Assets (MRQ)Greater than0.05-0.683
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Sienna Biopharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Sienna Biopharmaceuticals Inc

Sienna Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs in various therapeutic areas. It develops therapies in immunology and inflammation that target select pathways in tissues, such as skin. The company's lead product candidates include SNA-120, a first-in-class inhibitor of tropomyosin receptor kinase A, which is in a Phase IIb clinical trial for the treatment of psoriasis and associated pruritus; and SNA-125, a topical dual Janus kinase 3 inhibitor that is in Phase I/II clinical trials for the treatment of atopic dermatitis, psoriasis, and pruritus. It also develops SNA-001, a topical suspension of silver particles, which is in pivotal clinical trials for the treatment of acne, as well as for the reduction of light-pigmented hair, including white, gray, blonde, light brown, and light red hair. The company was formerly known as Sienna Labs, Inc. and changed its name to Sienna Biopharmaceuticals, Inc. in February 2016. Sienna Biopharmaceuticals, Inc. was founded in 2010 and is headquartered in Westlake Village, California. On December 18, 2019, Sienna Biopharmaceuticals, Inc. filed a voluntary petition for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 16, 2019.

Fundamental data was last updated by Penke on 2024-11-28 06:18:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Sienna Biopharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Sienna Biopharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sienna Biopharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--113.9%+113.9%
TTM--214.4%+214.4%
YOY--210.0%+210.0%
5Y--339.1%+339.1%
10Y--464.5%+464.5%
4.3.1.2. Return on Assets

Shows how efficient Sienna Biopharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sienna Biopharmaceuticals Inc to the Biotechnology industry mean.
  • -68.3% Return on Assets means that Sienna Biopharmaceuticals Inc generated $-0.68 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sienna Biopharmaceuticals Inc:

  • The MRQ is -68.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -68.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-68.3%TTM-68.3%0.0%
TTM-68.3%YOY-36.9%-31.4%
TTM-68.3%5Y-84.1%+15.8%
5Y-84.1%10Y-84.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-68.3%-11.1%-57.2%
TTM-68.3%-11.7%-56.6%
YOY-36.9%-11.3%-25.6%
5Y-84.1%-12.7%-71.4%
10Y-84.1%-14.3%-69.8%
4.3.1.3. Return on Equity

Shows how efficient Sienna Biopharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sienna Biopharmaceuticals Inc to the Biotechnology industry mean.
  • -46.0% Return on Equity means Sienna Biopharmaceuticals Inc generated $-0.46 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sienna Biopharmaceuticals Inc:

  • The MRQ is -46.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -46.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-46.0%TTM-46.0%0.0%
TTM-46.0%YOY-58.8%+12.8%
TTM-46.0%5Y-120.6%+74.6%
5Y-120.6%10Y-120.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-46.0%-14.2%-31.8%
TTM-46.0%-15.8%-30.2%
YOY-58.8%-14.2%-44.6%
5Y-120.6%-18.5%-102.1%
10Y-120.6%-19.5%-101.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Sienna Biopharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Sienna Biopharmaceuticals Inc is operating .

  • Measures how much profit Sienna Biopharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sienna Biopharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sienna Biopharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--224.9%+224.9%
TTM--306.4%+306.4%
YOY--223.5%+223.5%
5Y--386.5%+386.5%
10Y--497.6%+497.6%
4.3.2.2. Operating Ratio

Measures how efficient Sienna Biopharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Sienna Biopharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.508-2.508
TTM-3.295-3.295
YOY-3.298-3.298
5Y-4.788-4.788
10Y-6.517-6.517
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Sienna Biopharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Sienna Biopharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.07 means the company has $2.07 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Sienna Biopharmaceuticals Inc:

  • The MRQ is 2.070. The company is able to pay all its short-term debts. +1
  • The TTM is 2.070. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.070TTM2.0700.000
TTM2.070YOY9.386-7.315
TTM2.0705Y4.528-2.457
5Y4.52810Y4.5280.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0703.645-1.575
TTM2.0703.877-1.807
YOY9.3864.666+4.720
5Y4.5285.938-1.410
10Y4.5286.265-1.737
4.4.3.2. Quick Ratio

Measures if Sienna Biopharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sienna Biopharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 1.99 means the company can pay off $1.99 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sienna Biopharmaceuticals Inc:

  • The MRQ is 1.993. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.993. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.993TTM1.9930.000
TTM1.993YOY9.036-7.043
TTM1.9935Y4.217-2.224
5Y4.21710Y4.2170.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9933.093-1.100
TTM1.9933.432-1.439
YOY9.0364.478+4.558
5Y4.2175.927-1.710
10Y4.2176.424-2.207
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Sienna Biopharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Sienna Biopharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sienna Biopharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.75 means that Sienna Biopharmaceuticals Inc assets are financed with 75.2% credit (debt) and the remaining percentage (100% - 75.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sienna Biopharmaceuticals Inc:

  • The MRQ is 0.752. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.752. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.752TTM0.7520.000
TTM0.752YOY0.334+0.419
TTM0.7525Y0.507+0.245
5Y0.50710Y0.5070.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7520.354+0.398
TTM0.7520.345+0.407
YOY0.3340.311+0.023
5Y0.5070.366+0.141
10Y0.5070.383+0.124
4.5.4.2. Debt to Equity Ratio

Measures if Sienna Biopharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sienna Biopharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 50.7% means that company has $0.51 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sienna Biopharmaceuticals Inc:

  • The MRQ is 0.507. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.507. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.507TTM0.5070.000
TTM0.507YOY0.531-0.025
TTM0.5075Y0.820-0.313
5Y0.82010Y0.8200.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5070.396+0.111
TTM0.5070.436+0.071
YOY0.5310.380+0.151
5Y0.8200.451+0.369
10Y0.8200.493+0.327
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Sienna Biopharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Sienna Biopharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of -0.98 means the investor is paying $-0.98 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sienna Biopharmaceuticals Inc:

  • The EOD is 0.000. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.976. Based on the earnings, the company is expensive. -2
  • The TTM is -0.976. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-0.976+0.976
MRQ-0.976TTM-0.9760.000
TTM-0.976YOY-11.098+10.122
TTM-0.9765Y-3.019+2.043
5Y-3.01910Y-3.0190.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-2.220+2.220
MRQ-0.976-2.398+1.422
TTM-0.976-3.148+2.172
YOY-11.098-3.237-7.861
5Y-3.019-6.033+3.014
10Y-3.019-6.685+3.666
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sienna Biopharmaceuticals Inc:

  • The EOD is 0.000. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.162. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.162. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-1.162+1.162
MRQ-1.162TTM-1.1620.000
TTM-1.162YOY-13.564+12.402
TTM-1.1625Y-3.681+2.520
5Y-3.68110Y-3.6810.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-2.988+2.988
MRQ-1.162-3.276+2.114
TTM-1.162-3.734+2.572
YOY-13.564-4.523-9.041
5Y-3.681-8.321+4.640
10Y-3.681-9.273+5.592
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Sienna Biopharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.70 means the investor is paying $2.70 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Sienna Biopharmaceuticals Inc:

  • The EOD is 0.000. Based on the equity, the company is cheap. +2
  • The MRQ is 2.698. Based on the equity, the company is underpriced. +1
  • The TTM is 2.698. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.000MRQ2.698-2.698
MRQ2.698TTM2.6980.000
TTM2.698YOY6.151-3.453
TTM2.6985Y2.212+0.485
5Y2.21210Y2.2120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0001.894-1.894
MRQ2.6982.027+0.671
TTM2.6982.356+0.342
YOY6.1512.418+3.733
5Y2.2123.686-1.474
10Y2.2124.357-2.145
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2018-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets107,306
Total Liabilities80,725
Total Stockholder Equity159,368
 As reported
Total Liabilities 80,725
Total Stockholder Equity+ 159,368
Total Assets = 107,306

Assets

Total Assets107,306
Total Current Assets50,412
Long-term Assets56,894
Total Current Assets
Cash And Cash Equivalents 48,526
Total Current Assets  (as reported)50,412
Total Current Assets  (calculated)48,526
+/- 1,886
Long-term Assets
Property Plant Equipment 311
Goodwill 10,989
Intangible Assets 45,594
Other Assets 45,594
Long-term Assets  (as reported)56,894
Long-term Assets  (calculated)102,488
+/- 45,594

Liabilities & Shareholders' Equity

Total Current Liabilities24,349
Long-term Liabilities56,376
Total Stockholder Equity159,368
Total Current Liabilities
Accounts payable 2,792
Other Current Liabilities 21,557
Total Current Liabilities  (as reported)24,349
Total Current Liabilities  (calculated)24,349
+/-0
Long-term Liabilities
Long-term Liabilities Other 15,748
Deferred Long Term Liability 45,594
Long-term Liabilities  (as reported)56,376
Long-term Liabilities  (calculated)61,342
+/- 4,966
Total Stockholder Equity
Retained Earnings 159,368
Accumulated Other Comprehensive Income 3,199
Other Stockholders Equity -3,199
Total Stockholder Equity (as reported)159,368
Total Stockholder Equity (calculated)159,368
+/-0
Other
Cash and Short Term Investments 48,526
Common Stock Shares Outstanding 20,450
Liabilities and Stockholders Equity 240,093
Net Debt -18,401
Net Invested Capital 56,706
Net Tangible Assets 15,592
Net Working Capital 26,063
Short Long Term Debt Total 30,125



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2018-12-312017-12-312016-12-312015-12-31
> Total Assets 
5,754
62,377
136,847
107,306
107,306136,84762,3775,754
   > Total Current Assets 
5,640
10,523
77,346
50,412
50,41277,34610,5235,640
       Cash And Cash Equivalents 
4,962
9,091
74,467
48,526
48,52674,4679,0914,962
       Other Current Assets 
24
94
2,879
50,412
50,4122,8799424
   > Long-term Assets 
114
51,854
59,501
56,894
56,89459,50151,854114
       Property Plant Equipment 
114
291
432
311
311432291114
       Goodwill 
0
9,698
11,472
10,989
10,98911,4729,6980
       Intangible Assets 
0
41,863
47,597
45,594
45,59447,59741,8630
       Other Assets 
0
41,865
47,597
45,594
45,59447,59741,8650
> Total Liabilities 
1,703
40,260
45,648
80,725
80,72545,64840,2601,703
   > Total Current Liabilities 
1,009
9,883
8,241
24,349
24,3498,2419,8831,009
       Accounts payable 
806
1,691
2,357
2,792
2,7922,3571,691806
       Other Current Liabilities 
203
8,192
5,884
21,557
21,5575,8848,192203
   > Long-term Liabilities 
694
30,377
37,407
56,376
56,37637,40730,377694
       Other Liabilities 
694
30,377
37,407
26,251
26,25137,40730,377694
       Deferred Long Term Liability 
0
41,863
47,597
45,594
45,59447,59741,8630
> Total Stockholder Equity
4,051
22,117
85,897
159,368
159,36885,89722,1174,051
   Common Stock
1
1
2
0
0211
   Retained Earnings Total Equity0000
   Accumulated Other Comprehensive Income 
0
-366
5,370
3,199
3,1995,370-3660
   Capital Surplus 0000
   Treasury Stock0000
   Other Stockholders Equity 
-2,110
57,834
-5,372
-3,199
-3,199-5,37257,834-2,110



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2022-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue-
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense--
Operating Income-0
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense-0
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-0
EBIT - interestExpense = 0
0
0
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-0
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-0
Net Income-
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Sienna Biopharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sienna Biopharmaceuticals Inc. The general trend of Sienna Biopharmaceuticals Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sienna Biopharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sienna Biopharmaceuticals Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
Sienna Biopharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sienna Biopharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sienna Biopharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sienna Biopharmaceuticals Inc. The current macd is 0.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sienna Biopharmaceuticals Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Sienna Biopharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Sienna Biopharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Sienna Biopharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartSienna Biopharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sienna Biopharmaceuticals Inc. The current adx is 0.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is 0/(-7 +7).

  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Sienna Biopharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sienna Biopharmaceuticals Inc. The current sar is 0.0001.

Sienna Biopharmaceuticals Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sienna Biopharmaceuticals Inc. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Sienna Biopharmaceuticals Inc Daily Relative Strength Index (RSI) ChartSienna Biopharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sienna Biopharmaceuticals Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sienna Biopharmaceuticals Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Sienna Biopharmaceuticals Inc Daily Stochastic Oscillator ChartSienna Biopharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sienna Biopharmaceuticals Inc. The current cci is -66.66666667.

Sienna Biopharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartSienna Biopharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sienna Biopharmaceuticals Inc. The current cmo is 0.

Sienna Biopharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartSienna Biopharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sienna Biopharmaceuticals Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Sienna Biopharmaceuticals Inc Daily Williams %R ChartSienna Biopharmaceuticals Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sienna Biopharmaceuticals Inc.

Sienna Biopharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sienna Biopharmaceuticals Inc. The current atr is 0.

Sienna Biopharmaceuticals Inc Daily Average True Range (ATR) ChartSienna Biopharmaceuticals Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sienna Biopharmaceuticals Inc. The current obv is 0.

Sienna Biopharmaceuticals Inc Daily On-Balance Volume (OBV) ChartSienna Biopharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sienna Biopharmaceuticals Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Sienna Biopharmaceuticals Inc Daily Money Flow Index (MFI) ChartSienna Biopharmaceuticals Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sienna Biopharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal

6.3. Candlestick Patterns

Sienna Biopharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sienna Biopharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Sienna Biopharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Sienna Biopharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sienna Biopharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sienna Biopharmaceuticals Inc

I send you an email if I find something interesting about Sienna Biopharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Sienna Biopharmaceuticals Inc.

Receive notifications about Sienna Biopharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.